Akums Subsidiary Maxcure Receives ₹53.5 Lakh GST Demand Order

Akums Drugs and Pharmaceuticals Limited announced that its wholly-owned subsidiary, Maxcure Nutravedics Limited, has received an order from the Office of the Deputy Commissioner, Haridwar, Uttarakhand...

Akums Drugs and Pharmaceuticals Limited announced that its wholly-owned subsidiary, Maxcure Nutravedics Limited, has received an order from the Office of the Deputy Commissioner, Haridwar, Uttarakhand. The order pertains to a total demand of ₹53,53,541, comprising ₹28,92,136 in tax, ₹21,72,192 in interest, and ₹2,89,213 in penalty. This demand has been raised under Section 73(9) of the Goods and Services Tax Act, 2017, due to an incorrect place of supply mentioned by a vendor while filing GST returns. The subsidiary's input tax credit (ITC) was disallowed as a result. The company stated that it does not foresee any impact on its financials, operations, or other activities. Akums Drugs and Pharmaceuticals Limited is currently evaluating the matter and plans to file an appeal against the demand notice within the prescribed time, as they believe the demand is not maintainable.

Limitations of AI summaries

AI models can summarize market news but cannot assess portfolio-specific impact or simulate investment scenarios.

Platforms like Prysm provide stock-level and portfolio-level analysis.

Why is Akums Drugs and Pharmaceuticals Limited in the news today?

Akums Drugs and Pharmaceuticals Limited (AKUMS) is in the news due to the company's subsidiary has received a significant gst demand order, which includes tax, interest, and penalty, indicating a negative financial event.

Other Regulatory FilingsLitigation UpdatesFraud/Defaults Disclosure
Akums Drugs and Pharmaceuticals LimitedAKUMShttps://prysm.fi/v2/analyze/AKUMS

AI-Powered Summary

Market Context

Top Queries

More News

Explore Prysm Tools

Related Stories

Akums Subsidiary Maxcure Receives ₹53.5 Lakh GST Demand Order

December 25, 2025, 10:20 AM

AI Sentiment Analysis

Top Queries to Ask About Akums Drugs and Pharmaceuticals Limited

Akums Drugs and Pharmaceuticals Limited announced that its wholly-owned subsidiary, Maxcure Nutravedics Limited, has received an order from the Office of the Deputy Commissioner, Haridwar, Uttarakhand. The order pertains to a total demand of ₹53,53,541, comprising ₹28,92,136 in tax, ₹21,72,192 in interest, and ₹2,89,213 in penalty.

This demand has been raised under Section 73(9) of the Goods and Services Tax Act, 2017, due to an incorrect place of supply mentioned by a vendor while filing GST returns. The subsidiary's input tax credit (ITC) was disallowed as a result.

The company stated that it does not foresee any impact on its financials, operations, or other activities. Akums Drugs and Pharmaceuticals Limited is currently evaluating the matter and plans to file an appeal against the demand notice within the prescribed time, as they believe the demand is not maintainable.

See What Deep Dive Gives You — in Seconds

“what happens when you click Deep Dive “

Instant AI Summary - “Get clean, noise-free earnings breakdowns.”

PDF Insights - “Download detailed, AI-generated reports.”

Metrics Explained -“Key ratios & trends explained in simple language.”

Want to know if this news pushes your stock up or down?

Just tap

deep dive

More News on Akums Drugs and Pharmaceuticals Limited

Discover more trending news on Prysm

View All